SECRET ROSE Trademark

Trademark Overview


On Thursday, August 5, 2021, a trademark application was filed for SECRET ROSE with the United States Patent and Trademark Office. The USPTO has given the SECRET ROSE trademark a serial number of 90866850. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, July 22, 2024. This trademark is owned by Medi n research Co., Ltd.. The SECRET ROSE trademark is filed in the Medical Instrument Products category with the following description:

Thread for medical use; Medical thread inserter being surgical apparatus; Medical apparatus for injecting fillers, namely, medical syringes; Medical surgical instruments for use in dermatoplasty; Silicone preparations for cosmetic implantation being implants consisting of artificial materials
secret rose

General Information


Serial Number90866850
Word MarkSECRET ROSE
Filing DateThursday, August 5, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements


Description of MarkThe mark consists of a larger-sized rose with a partial human face shape on the left side of the rose, all of which is over the stylized wording "Secret Rose" where the letter "o" is substitutes with a smaller-sized rose.
Goods and ServicesThread for medical use; Medical thread inserter being surgical apparatus; Medical apparatus for injecting fillers, namely, medical syringes; Medical surgical instruments for use in dermatoplasty; Silicone preparations for cosmetic implantation being implants consisting of artificial materials

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedi n research Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJeollabuk-do 54896
KR

Party NameMedi n research Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJeollabuk-do 54896
KR

Trademark Events


Event DateEvent Description
Thursday, September 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 1, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, August 9, 2021NEW APPLICATION ENTERED
Tuesday, May 3, 2022ASSIGNED TO EXAMINER
Wednesday, November 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2022NON-FINAL ACTION WRITTEN
Wednesday, May 4, 2022NON-FINAL ACTION E-MAILED
Wednesday, May 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Friday, July 28, 2023SOU EXTENSION 1 FILED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 28, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 28, 2023SOU EXTENSION 1 GRANTED
Monday, January 29, 2024SOU EXTENSION 2 GRANTED
Monday, January 29, 2024SOU EXTENSION 2 FILED
Tuesday, August 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 22, 2024SOU EXTENSION 3 FILED
Wednesday, December 18, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024SOU EXTENSION 3 GRANTED